<scp>N<sup>6</sup></scp>‐methyladenosine‐modified <scp>FAM111A‐DT</scp> promotes hepatocellular carcinoma growth via epigenetically activating <scp>FAM111A</scp>

Jian Pu(Affiliated Hospital of Youjiang Medical University for Nationalities), Huamei Wei(Affiliated Hospital of Youjiang Medical University for Nationalities)
Cancer Science
July 3, 2023
10.1111/cas.15886
Cited by 18

Related Papers

Long non-coding RNA PAARH promotes hepatocellular carcinoma progression and angiogenesis via upregulating HOTTIP and activating HIF-1α/VEGF signaling
|Cell Death and Disease|2022|76
Long non-coding RNA HOMER3-AS1 drives hepatocellular carcinoma progression via modulating the behaviors of both tumor cells and macrophages
|Cell Death and Disease|2021|28
ADORA2A-AS1 Restricts Hepatocellular Carcinoma Progression via Binding HuR and Repressing FSCN1/AKT Axis
|Frontiers in Oncology|2021|23
METTL3 and METTL14-mediated N6-methyladenosine modification of SREBF2-AS1 facilitates hepatocellular carcinoma progression and sorafenib resistance through DNA demethylation of SREBF2
|Scientific Reports|2024|10
ZNNT1/osteopontin/S100A9 feedback loop promote hepatocellular carcinoma progression via mediating crosstalk between hepatocellular carcinoma cells and macrophages
|Research Square|2022|0